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an We Improve Upon
uman Performance in the
lectrophysiology Laboratory?*
avid J. Callans, MD, FACC
hiladelphia, Pennsylvania
The future offers very little hope for those who expect that our
new mechanical slaves will offer us a world in which we may
rest from thinking.
Norbert Wiener (1)
fter the initial frenetic excitement over seminal observa-
ions leading to our ability to treat atrial fibrillation (AF)
ith catheter ablation, we have reached a plateau, marked
y little momentum in the fight against this adversary.
lthough the procedure is getting progressively safer (2),
here are little but exaggerated claims to suggest significant
mprovement in efficacy, particularly in patients with more
stablished AF. There is a general sense that the next
reakthrough is eminent, but it is unclear whether it will be
upplied by a better understanding of the underlying patho-
hysiology leading to new ablation strategies or by improve-
ents in technology leading to more effective ways of
erforming the present procedure.
See page 2407
The study by Saliba et al. (3) in this issue of the Journal
ay provide some insight into the feasibility of a technology
hat may prove helpful. They present a multicenter experi-
nce with ablation of atrial fibrillation and atrial flutter using
robotic steerable guiding sheath (Artisan Control Cathe-
er, Sensei Robotic System, Hansen Medical, Mountain
iew, California). This system uses a master-slave electro-
echanical system to direct a 14-F steerable sheath to guide
nd potentially stabilize the ablation catheter. Pulmonary
ein antral isolation was performed in 40 patients with
rug-refractory AF (30 paroxysmal, 10 “recently persis-
ent”); in addition, isthmus-dependent atrial flutter was also
blated in 23 patients. After the first transseptal puncture,
ll other elements of the procedure (the second transseptal
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.m
From the Department of Medicine, Section of Cardiovascular Disease, University
f Pennsylvania, Philadelphia, Pennsylvania.uncture, pulmonary vein and superior vena cava isolation,
sthmus ablation) were performed with use of the robotic
ystem. Procedures were also guided by intracardiac echo-
ardiography and electroanatomic mapping; the data from
hese modalities are also imported for online assessment on
he physician workstation. Ablation was performed with an
xternally irrigated catheter. The study was designed to
ssess the following end points: acute success (pulmonary
ein and superior vena cava isolation, bidirectional isthmus
lock), procedural safety, and recurrence of atrial arrhyth-
ias without use of antiarrhythmic drugs at 12 months.
The mean procedural and fluoroscopy times were re-
orted to be 163  88 min and 64  33 min, respectively.
his result is a little misleading, because AF and flutter
blations were counted as separate procedures. The proce-
ural and fluoroscopic times for AF procedures specifically
ere 189 88 min and 83 15 min, respectively. All acute
rocedural end points were achieved with the use of robotic
avigation. There were few procedural complications: car-
iac perforation leading to tamponade was observed in 2
atients (1 perforation related to the initial, non-robotic
ransseptal procedure, 1 apparently caused by ablation [50
] using the system). At 12 months after a single proce-
ure, 34 patients were free from the symptomatic recurrence
f atrial arrhythmias from the use of antiarrhythmic drugs,
nd an additional 5 patients were free from symptomatic
rrhythmias who were using previously ineffective antiar-
hythmic drugs. The authors concluded that the robotic
ystem is feasible and safe and that despite the high
ncidence of tamponade, “there does not appear to be any
ncreased risk of perforation or intracardiac damage as-
ociated with this . . . system.” Furthermore, because of
he physical separation of the Sensei control system and the
uoroscopy unit, the operator’s radiation exposure was
ramatically reduced.
The authors should be congratulated for this initial effort.
agree that the feasibility and safety of the system has been
emonstrated, although there are some lingering concerns.
espite the outstanding caliber and experience of the
nvestigators, there was a high incidence of perforation in
he experience, although only 1 perforation in 39 procedures
sing the system was noted. This complication is potentially
nstructive, regardless of whether the cause was actually an
verpowered ablation lesion or excessive force delivered to
he atrial wall. Robotic control has the potential to com-
letely change the way that radiofrequency energy is deliv-
red (see herein). The contact force issue may eventually be
olved by a contact sensor, which is available in current
odels but not during the period of the study. The efficacy
eported in this experience is phenomenal, and although not
eally the focus of this investigation, it underscores the vital
eed for more uniform post-procedural monitoring and
eporting of results as called for by recent consensus docu-
ents (4,5).
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June 24, 2008:2412–3 Editorial CommentMore interesting is the potential promise of this technol-
gy, which this study was not designed to investigate. As the
uthors state, one of the major limitations of manual
atheter manipulation is tissue contact. It is well docu-
ented that irrigated radiofrequency delivery in normal
issue in vitro results in very large lesions (6). It would follow
hat robotic technology that would enhance catheter contact
ould ensure extensive lesion creation, maybe even to a
angerous degree until we readjust dosing strategies.
hether the actual parameter that is important is catheter
orce (potentially adjustable with the Hansen system) or
ontact (which may be optimized with the Stereotaxis system)
s not completely clear and may be of more than passing
onsequence in the battle between competing technologies.
The introduction of robotic technologies is, of course, not
nique to electrophysiology. In the surgery arena, robotic
rocedures allow intuitive multidimensional complex move-
ents of instruments in places in which incisions are too
mall to admit the human hand. Most electrophysiologists
alue intellectual and integrative skills more than the tech-
ical. In any case, it is not clear that more dexterity is
eeded during AF ablation; the potential benefit really
epends on whether improved catheter stability provides
ore efficient and consistent energy delivery. The imple-
entation of robotic systems in surgery has provided some
xcitement and a fair amount of skepticism. In a general
eview, it was concluded that despite significant promise,
Up to this point, the race to acquire and incorporate this
merging technology has primarily been driven by the
arket” (7). Even in the relatively well-established applica-
ion for prostatectomy, although observational series suggest
reduction in both blood loss and surgical complications
uch as erectile dysfunction and incontinence, “no random-
zed trials have been published that have compared tradi-
ional treatment with minimally invasive treatments” (8).
I really hope that the question posed in the title of this
ditorial is “yes.” However, at the risk of being called a
uddite, advanced technologies in general will only be
8mplemented if they add value to balance their considerable
ost. This value needs to be measurable in terms of improving
fficacy of routine procedures, allowing us to do complex
rocedures that would be otherwise impossible, or improving
aboratory efficiency and safety. Eventually, the authors of
arefully designed studies will evaluate whether real value is
dded by incremental technology; these studies should be
erformed after the centers involved have mastered use of the
echnology, to prevent bias. This observational study by Saliba
t al. (2) provides a starting point for hypothesis driven trials to
stablish the real value of this technology.
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